Related Experiment Videos
Prostacyclin in severe peripheral vascular disease.
Archives of Disease in Childhood
|April 1, 1985
Summary
Prostacyclin, a medication, halted gangrene progression in a child with peripheral vascular disease. Toe regrowth is now observed, indicating potential for limb salvage in similar cases.
Area of Science:
- Vascular Biology
- Pediatric Cardiology
- Pharmacology
Background:
- Familial peripheral vascular disease (PVD) can lead to severe complications like gangrene.
- Limited treatment options exist for pediatric PVD, especially when the cause is unexplained.
- Gangrene signifies tissue death due to insufficient blood supply, often necessitating amputation.
Observation:
- A 6-year-old boy presented with gangrene in his feet due to familial PVD.
- The patient's condition was previously unexplained and resistant to standard treatments.
- Prostacyclin (prostaglandin I2, epoprostenol sodium) was administered to address the vascular issue.
Findings:
- Prostacyclin effectively arrested the progression of gangrene in the affected feet.
- Following treatment, toe regrowth commenced at the line of demarcation.
- This suggests a reversal of tissue damage and improved circulation.
Implications:
- Prostacyclin therapy may offer a novel approach for managing pediatric peripheral vascular disease and gangrene.
- Early intervention with prostacyclin could potentially prevent limb loss and improve patient outcomes.
- Further research is warranted to explore the long-term efficacy and safety of prostacyclin in pediatric PVD.